Cited by 245Gestational Diabetes Research and ManagementDiabetes Management and ResearchPregnancy and Medication Impact

Gestational diabetes mellitus

Open access
Alfadhli, Eman M.·2015·Saudi Medical Journal

Abstract

Gestational diabetes mellitus (GDM) is the most common medical complication of pregnancy. It is associated with maternal and neonatal adverse outcomes. Maintaining adequate blood glucose levels in GDM reduces morbidity for both mother and baby. There is a lack of uniform strategies for screening and diagnosing GDM globally. This review covers the latest update in the diagnosis and management of GDM. The initial treatment of GDM consists of diet and exercise. If these measures fail to achieve glycemic goals, insulin should be initiated. Insulin analogs are more physiological than human insulin, and are associated with less risk of hypoglycemia, and may provide better glycemic control. Insulin lispro, aspart, and detemir are approved to be used in pregnancy. Insulin glargine is not approved in pregnancy, but the existing studies did not show any contraindications. The use of oral hypoglycemic agents; glyburide and metformin seems to be safe and effective in pregnancy.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.15537/smj.2015.4.10307

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 49

  1. [1]Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. National Diabetes Data Group Diabetes 1979 28 1039 1057 510803
  2. [4]World Health Organization Diagnostic criteria and classification of hyperglycaemia first detected in pregnancy 2013 Geneva (CH) World Health Organization Available from: http: //130.14.29.110/books/NBK169024 24199271
  3. [5]Bevier WC Jovanovic-Peterson L Peterson CM Pancreatic disorders of pregnancy. Diagnosis, management, and outcome of gestational diabetes Endocrinol Metab Clin North Am 1995 24 103 138 7781621
  4. [7]Agarwal MM Dhatt GS Shah SM Gestational Diabetes Mellitus Simplifying the International Association of Diabetes and Pregnancy diagnostic algorithm using fasting plasma glucose Diabetes Care 2010 33 2018 2020 20519664 PMC2928355
  5. [8]Dahanayaka NJ Agampodi SB Ranasinghe OR Jayaweera PM Wickramasinghe WA Adhikari AN Inadequacy of the risk factor based approach to detect gestational diabetes mellitus Ceylon Med J 2012 57 5 9 22453704
  6. [11]Jenum AK Mørkrid K Sletner L Vangen S Torper JL Nakstad B Impact of ethnicity on gestational diabetes identified with the WHO and the modified International Association of Diabetes and Pregnancy Study Groups criteria: a population-based cohort study Eur J Endocrinol 2012 166 317 324 22108914 PMC3260695
  7. [12]Mission JF Ohno MS Cheng YW Caughey AB Gestational diabetes screening with the new IADPSG guidelines: a cost-effectiveness analysis Am J Obstet Gynecol 2012 207 326 22840972 PMC4621259
  8. [13]Morikawa M Yamada T Akaishi R Nishida R Cho K Minakami H Change in the number of patients after the adoption of IADPSG criteria for hyperglycemia during pregnancy in Japanese women Diabetes Res Clin Pract 2010 90 339 342 20870307
  9. [14]Reyes-Muñoz E Parra A Castillo-Mora A Ortega-González C Effect of the diagnostic criteria of the International Association of Diabetes and Pregnancy Study Groups on the prevalence of gestational diabetes mellitus in urban Mexican women: a cross-sectional study Endocr Pract 2012 18 146 151 21856596
  10. [15]Sacks DA Hadden DR Maresh M Deerochanawong C Dyer AR Metzger BE Frequency of Gestational Diabetes Mellitus at Collaborating Centers Based on IADPSG Consensus Panel-Recommended Criteria The Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study Diabetes Care 2012 35 526 528 22355019 PMC3322716
  11. [16]Moses RG Gestational diabetes mellitus: implications of an increased frequency with IADPSG criteria Diabetes Care 2012 35 461 462 22355016 PMC3322706
  12. [18]Kjos SL Buchanan TA Gestational diabetes mellitus N Engl J Med 1999 341 1749 1756 10580075
  13. [21]Catalano PM Tyzbir ED Roman NM Amini SB Sims EA Longitudinal changes in insulin release and insulin resistance in nonobese pregnant women Am J Obstet Gynecol 1991 165 1667 1672 1750458
  14. [23]Solomon CG Willett WC Carey VJ Rich-Edwards J Hunter DJ Colditz GA A prospective study of pregravid determinants of gestational diabetes mellitus JAMA 1997 278 1078 1083 9315766
  15. [24]Kim C Newton KM Knopp RH Gestational Diabetes and the Incidence of Type 2 Diabetes A systematic review Diabetes Care 2002 25 1862 1868 12351492
  16. [25]Dabelea D Pettitt D Intrauterine diabetic environment confers risks for type 2 diabetes mellitus and obesity in the offspring, in addition to genetic susceptibility J Pediatr Endocrinol Metab 2001 14 1085 1091 11592564
  17. [26]O’Sullivan J Mahan C Criteria for the oral glucose tolerance test in pregnancy Diabetes 1964 13 278 285 14166677
  18. [28]Alberti KG Zimmet PZ Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation Diabet Med 1998 15 539 553 9686693
  19. [29]Committee on Practice Bulletins--Obstetrics. Practice Bulletin No. 137: Gestational diabetes mellitus Obstet Gynecol 2013 12 406 416 23969827
  20. [30]National Institutes of Health consensus development conference statement: diagnosing gestational diabetes mellitus, March 4-6, 2013 Obstet Gynecol 2013 122 358 369 23969806
  21. [33]Jovanovic-Peterson L Peterson CM Reed GF Metzger BE Mills JL Knopp RH Maternal postprandial glucose levels and infant birth weight: the Diabetes in Early Pregnancy Study. The National Institute of Child Health and Human Development--Diabetes in Early Pregnancy Study Am J Obstet Gynecol 1991 164 103 111 1986596
  22. [34]de Veciana M Major CA Morgan MA Asrat T Toohey JS Lien JM Postprandial versus preprandial blood glucose monitoring in women with gestational diabetes mellitus requiring insulin therapy N Engl J Med 1995 333 1237 1241 7565999
  23. [35]Jovanovič L Savas H Mehta M Trujillo A Pettitt DJ Frequent monitoring of A1C during pregnancy as a treatment tool to guide therapy Diabetes Care 2011 34 53 54 20921215 PMC3005444
  24. [36]Metzger BE Buchanan TA Coustan DR de Leiva A Dunger DB Hadden DR Summary and Recommendations of the Fifth International Workshop-Conference on Gestational Diabetes Mellitus Diabetes Care 2007 30 Supplement 2 S251 S260 17596481
  25. [37]Jovanovic L Role of diet and insulin treatment of diabetes in pregnancy Clin Obstet Gynecol 2000 43 46 55 10694987
  26. [38]American Diabetes Association Bantle JP Wylie-Rosett J Albright AL Apovian CM Clark NG Nutrition recommendations and interventions for diabetes: a position statement of the American Diabetes Association Diabetes Care 2008 31 S61 S78 18165339
  27. [39]Cheng YW Chung JH Kurbisch-Block I Inturrisi M Shafer S Caughey AB Gestational weight gain and gestational diabetes mellitus: perinatal outcomes Obstet Gynecol 2008 112 1015 1022 18978100
  28. [40]Rasmussen KM Catalano PM Yaktine AL New guidelines for weight gain during pregnancy: what obstetrician/gynecologists should know Curr Opin Obstet Gynecol 2009 21 521 526 19809317 PMC2847829
  29. [41]Pettitt DJ Ospina P Kolaczynski JW Jovanovic L Comparison of an insulin analog, insulin aspart, and regular human insulin with no insulin in gestational diabetes mellitus Diabetes Care 2003 26 183 186 12502678
  30. [42]Mecacci F Carignani L Cioni R Bartoli E Parretti E La Torre P Maternal metabolic control and perinatal outcome in women with gestational diabetes treated with regular or lispro insulin: comparison with non-diabetic pregnant women Eur J Obstet Gynecol Reprod Biol 2003 111 19 24 14557006
  31. [43]Mathiesen ER Hod M Ivanisevic M Garcia SD Brøndsted L Jovanovič L Maternal efficacy and safety outcomes in a randomized, controlled trial comparing insulin detemir with NPH insulin in 310 pregnant women with type 1 diabetes Diabetes Care 2012 35 2012 2017 22851598 PMC3447831
  32. [44]Pollex E Moretti ME Koren G Feig DS Safety of insulin glargine use in pregnancy: a systematic review and meta-analysis Ann Pharmacother 2011 45 9 16 21205954
  33. [45]Price N Bartlett C Gillmer M Use of insulin glargine during pregnancy: a case–control pilot study BJOG 2007 114 453 457 17261126
  34. [46]Elliott BD Langer O Schenker S Johnson RF Insignificant transfer of glyburide occurs across the human placenta Am J Obstet Gynecol 1991 165 807 812 1951536
  35. [47]Langer O Conway DL Berkus MD Xenakis EM-J Gonzales O A comparison of glyburide and insulin in women with gestational diabetes mellitus N Engl J Med 2000 343 1134 1138 11036118
  36. [50]Langer O Yogev Y Xenakis EM Rosenn B Insulin and glyburide therapy: dosage, severity level of gestational diabetes, and pregnancy outcome Am J Obstet Gynecol 2005 192 134 139 15672015
  37. [51]Eyal S Easterling TR Carr D Umans JG Miodovnik M Hankins GD Pharmacokinetics of metformin during pregnancy Drug Metab Dispos 2010 38 833 840 20118196 PMC2872944
  38. [52]Nawaz FH Khalid R Naru T Rizvi J Does continuous use of metformin throughout pregnancy improve pregnancy outcomes in women with polycystic ovarian syndrome? J Obstet Gynaecol Res 2008 34 832 837 18834342
  39. [53]Bolton S Cleary B Walsh J Dempsey E Turner M Continuation of metformin in the first trimester of women with polycystic ovarian syndrome is not associated with increased perinatal morbidity Eur J Pediatr 2009 168 203 206 18461356
  40. [55]Gabbe SG Gregory RP Power ML Williams SB Schulkin J Management of diabetes mellitus by obstetrician-gynecologists Obstet Gynecol 2004 103 1229 1234 15172857
  41. [57]Lurie S Insler V Hagay ZJ Induction of labor at 38 to 39 weeks of gestation reduces the incidence of shoulder dystocia in gestational diabetic patients class A2 Am J Perinatol 1996 13 293 296 8863948
  42. [58]Flores-le Roux JA Sagarra E Benaiges D Hernandez-Rivas E Chillaron JJ Puig de Dou J A prospective evaluation of neonatal hypoglycaemia in infants of women with gestational diabetes mellitus Diabetes Res Clin Pract 2012 97 217 222 22537519
  43. [59]Jovanovic L Peterson CM Management of the pregnant, insulin-dependent diabetic woman Diabetes Care 1980 3 63 68 6996970
  44. [60]Baptiste-Roberts K Barone BB Gary TL Golden SH Wilson LM Bass EB Risk factors for type 2 diabetes among women with gestational diabetes: a systematic review Am J Med 2009 122 207 214 19272478 PMC6393925
  45. [61]Gunderson EP Breastfeeding After Gestational Diabetes Pregnancy Subsequent obesity and type 2 diabetes in women and their offspring Diabetes Care 2007 30 Supplement 2 S161 S168 17596466
  46. [62]O’Reilly MW Avalos G Dennedy MC O’Sullivan EP Dunne F Atlantic DIP: high prevalence of abnormal glucose tolerance post partum is reduced by breast-feeding in women with prior gestational diabetes mellitus Eur J Endocrinol 2011 165 953 959 21937504
  47. [63]Owen CG Martin RM Whincup PH Smith GD Cook DG Does breastfeeding influence risk of type 2 diabetes in later life?A quantitative analysis of published evidence Am J Clin Nutr 2006 84 1043 1054 17093156
  48. [64]Glueck CJ Wang P Metformin before and during pregnancy and lactation in polycystic ovary syndrome Expert Opin Drug Saf 2007 6 191 198 17367265
  49. [65]Glatstein MM Djokanovic N Garcia-Bournissen F Finkelstein Y Koren G Use of hypoglycemic drugs during lactation Can Fam Physician 2009 55 371 373 19366943 PMC2669004

Cited by

Sorted by citations

Authors
Alfadhli, E. M.
Affiliations
Taibah University (SA)
Corresponding author
Alfadhli, Eman M.
Venue
Saudi Medical Journal
Published
2015
Volume
36
Issue
4
Pages
399-406
ISSN
  • 0379-5284 (ISSN-L)
  • 1658-3175
OpenAlex
W1963613891
Cited by
245
References
12
Citations by year
2026: 14 · 2025: 33 · 2024: 27 · 2023: 41 · 2022: 38 · 2021: 31 · 2020: 31 · 2019: 14 · 2018: 5 · 2017: 6 · 2016: 4 · 2015: 1
FWCI
0.79
Type
journal article
Language
en
Open access
Licence
cc-by-nc-sa
Locations
  • Saudi Medical Journal (publishedVersion, cc-by-nc-sa)
  • PubMed Central (publishedVersion, cc-by-nc-sa)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Pregnancy and Medication Impact
Keywords
gestational diabetes mellitus, GDM diagnosis, GDM screening, glycemic control, insulin therapy, insulin analogues, insulin lispro, insulin aspart, insulin detemir, insulin glargine, diet and exercise, oral antidiabetic drugs, metformin, glibenclamide, hypoglycemia, maternal and neonatal outcomes
MeSH terms
Diet, Exercise Therapy, Female, Humans, Hypoglycemic Agents, Pregnancy, Risk Factors, Diabetes, Gestational

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review